Screening for Depression in Adults: A Summary of the Evidence for the U.S. Preventive Services Task Force

  1. Michael P. Pignone, MD, MPH;
  2. Bradley N. Gaynes, MD, MPH;
  3. Jerry L. Rushton, MD, MPH;
  4. Catherine Mills Burchell, MA;
  5. C. Tracy Orleans, PhD;
  6. Cynthia D. Mulrow, MD, MSc; and
  7. Kathleen N. Lohr, PhD
  1. From University of North Carolina Hospitals, Chapel Hill, and Research Triangle Institute, Research Triangle Park, North Carolina; University of Michigan, Ann Arbor, Michigan; Robert Wood Johnson Foundation, Princeton, New Jersey; and University of Texas Health Science Center, San Antonio, Texas.
    1. Figure 1. Summary estimate of relative risk for persistent depression for screening compared with no screening. Summary estimate of absolute risk reduction in persistent depression with screening compared with no screening.
      View larger version:
      Figure 1. Summary estimate of relative risk for persistent depression for screening compared with no screening. Summary estimate of absolute risk reduction in persistent depression with screening compared with no screening. Meta-analysis of the effect of screening and feedback on the proportion of patients with persistent depression.Top.Bottom.
    2. Figure 2. . Summary estimate of relative risk for persistent depression for screening compared with no screening. Summary estimate of absolute risk reduction in persistent depression with screening compared with no screening.
      View larger version:
      Figure 2. . Summary estimate of relative risk for persistent depression for screening compared with no screening. Summary estimate of absolute risk reduction in persistent depression with screening compared with no screening. Meta-analysis of the effect of screening and feedback on the proportion of patients with persistent depression, excluding the study by Katzelnick and colleagues(12)Top.Bottom.
    « Previous | Next Article »Table of Contents